Time dependent radiation exposures surrounding technetium-99m MDP patients
FP Castronovo - Journal of nuclear medicine technology, 1991 - Soc Nuclear Med
Radiation surveys of technetium-99m (99mTc) MDP bone scan patients were performed at 5
min, 4 hr, and 24 hr post administration. The measurement distances chosen were surface, 1 …
min, 4 hr, and 24 hr post administration. The measurement distances chosen were surface, 1 …
A mathematical method for determining radiation exposures surrounding technetium-99m-MDP patients
FP Castronovo - Journal of nuclear medicine technology, 1993 - Soc Nuclear Med
Radiation surveys of 16 technetium-99m-(99mTc) MDP bone scintigram prostate cancer
patients were obtained at 5 min, 4 hr, and 24 hr postadministration at survey distances of 1 ft …
patients were obtained at 5 min, 4 hr, and 24 hr postadministration at survey distances of 1 ft …
[PDF][PDF] Radiation absorbed dose from technetium-99m DTPA
T Smith, GD Zanelli, N Veall - Journal of nuclear medicine, 1987 - Soc Nuclear Med
Radiation Absorbed Dose from Technetium-99m DTPA Page 1 he radiation absorbed dose
from technetium-99m diethylenetriaminepentaacetic acid ([@mTc]DTPA) was the subjectof …
from technetium-99m diethylenetriaminepentaacetic acid ([@mTc]DTPA) was the subjectof …
[HTML][HTML] Assessment of Radiation Exposure in a Nuclear Medicine Department during 99mTc-MDP Bone Scintigraphy
SK Marshall, P Prom-On, S Sangkue, W Thiangsook - Toxics, 2023 - mdpi.com
This study measured 99mTc-MDP bone scintigraphy radiation risks, as low-dose radiation
exposure is a growing concern. Dosimeter measurements were taken at four positions (left …
exposure is a growing concern. Dosimeter measurements were taken at four positions (left …
Short-term retention of 99mTc activity in bone scintigraphy
The objective of present study is estimation of the radioactivity held within the urinary
bladder and kidneys 3 h post radiopharmaceutical (99m Tc-MDP) administration …
bladder and kidneys 3 h post radiopharmaceutical (99m Tc-MDP) administration …
24-Hour/4-hour ratio of technetium-99m methylene diphosphonate uptake in patients with bone metastases and degenerative bone changes.
O Israel, A Frenkel, U Kleinhaus - Journal of Nuclear Medicine …, 1985 - europepmc.org
The uptake of [99mTc] MDP in metastatic lesions of the vertebrae was compared with the
uptake in normal vertebrae. The ratio of these lesion-to-nonlesion uptakes at 4 and 24 hr …
uptake in normal vertebrae. The ratio of these lesion-to-nonlesion uptakes at 4 and 24 hr …
Radiation exposure in the vicinity of patients after administration of Tc-99m-DPD
J Preitfellner, A Kurtaran, E Havlik - Nuklearmedizin. Nuclear …, 1995 - europepmc.org
Dose rate measurements were performed in 0.5, 1 and 2 m distance from the surface of the
bodies of 16 patients within the first 4 h after they had received 600+/-30 MBq of 99mTc …
bodies of 16 patients within the first 4 h after they had received 600+/-30 MBq of 99mTc …
New criteria for scintigraphic follow-up of bone metastases following radiotherapy. Results of functional scintigraphy using 99mTc-MDP
J Knop, P Stritzke, G Langendorff - Nuklearmedizin. Nuclear …, 1985 - europepmc.org
After radiation therapy regional 99mTc-MDP clearance by 17 metastatic lesions was
determined repeatedly in 13 patients. 99mTc-MDP clearance rates decreased within 14 …
determined repeatedly in 13 patients. 99mTc-MDP clearance rates decreased within 14 …
A longitudinal comparison of the kinetics of 99mTc-MDP and 99mTc-EHDP in humans
L ROSENTHALL, A ARZOUMANIAN… - Clinical Nuclear …, 1977 - journals.lww.com
Abstract 99m Tc-MDP and 99m Tc-EHDP were compared in 11 volunteers and 20 patients
for blood retention, urinary excretion, bone to soft tissue background and overall quality of …
for blood retention, urinary excretion, bone to soft tissue background and overall quality of …
[PDF][PDF] Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication
BF Van Duzee, JA Schaefer, JD Ball… - Journal of nuclear …, 1984 - Soc Nuclear Med
revision accepted Sept. 8, 1983. For reprints contact: Barry F. Van Duzee, PhD, The Procter
& Gamble Company, Sharon Woods Technical Center, I151I Reed Hartman Highway …
& Gamble Company, Sharon Woods Technical Center, I151I Reed Hartman Highway …
Related searches
- radiation exposures technetium 99m
- radiation exposure 99mtc mdp
- radiation exposure vicinity of patients
- bone metastases technetium 99m
- radiation exposure bone scintigraphy
- tumour imaging technetium 99m
- 99mtc mdp longitudinal comparison
- 99m dpd vicinity of patients
- 99mtc mdp bone scintigraphy
- radiation exposures 99m mdp
- radiation exposure 99m dpd
- radiation exposure tc 99m
- bone changes technetium 99m
- bone metastases 99mtc mdp
- 99mtc mdp functional scintigraphy
- tc 99m vicinity of patients